Impaired renal haemodynamic response to L-arginine in essential hypertension: role of buffering anion and tubuloglomerular feedback
Authors:
- Nicoletta CarraNCNicoletta Carra
- Aderville CabassiACAderville Cabassi
- Angela Luciana BarilliABAngela Luciana Barilli
- Luisa MusiariLMLuisa Musiari
- Matteo IoriMIMatteo Iori
- Giuseppe De IacoGIGiuseppe De Iaco
- Matteo AzzaroneMAMatteo Azzarone
- Almerico NovariniANAlmerico Novarini
- Alberto MontanariAMAlberto Montanari
- 1 March 2007
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 25 (3) , 679-688
Abstract
To investigate whether changes in tubuloglomerular feedback (TGF) dependent upon the tubular effects of buffering anions affect the renal haemodynamic response to L-arginine in healthy (control) individuals and patients with essential hypertension. Mean arterial pressure (MAP), glomerular filtration rate (GFR), renal blood flow (RBF) and fractional excretion of sodium (FENa), chloride (FECl) and lithium (FELi) were measured in 10 control individuals and 10 hypertensive patients during two 3-h infusions of 0.012 mmol/kg per min L-arginine buffered with either HCl or citric acid. FELi, FECl and FENa increased (P < 0.001) comparably in controls and hypertensive individuals with arginine-HCl and decreased with arginine-citrate (P < 0.001). MAP was unchanged in controls with arginine-HCl and decreased by 3% with arginine-citrate (P < 0.001), and decreased in hypertensive individuals with both arginine-HCl and arginine-citrate (by 3 and 7%, respectively; P < 0.001). GFR increased with arginine-citrate in controls and hypertensive individuals (by 6.1 and 5.4%, respectively; P < 0.001), but did not change with arginine-HCl in controls and declined by 4.6% in hypertensive individuals (P < 0.05). RBF increased equally after arginine-citrate in controls and hypertensive individuals (by 34 and 33%, respectively; P < 0.001); it also increased after arginine-HCl (22 and 13%, respectively; P < 0.001), but less than after arginine-citrate (P < 0.001), and 41% less in hypertensive individuals than in controls (P < 0.001). Because arginine-HCl, unlike arginine-citrate, inhibits tubular reabsorption and elicits much less renal vasodilatation than does arginine-citrate, renal haemodynamics in response to L-arginine are modulated by changes in reabsorption and TGF according to the tubular effects of the attendant anion. As renal vasodilatation in hypertensive individuals was reduced only with arginine-HCl, which activates TGF, the blunted vasodilatation of the hypertensive kidney in response to arginine-HCl reflects an exaggerated response to an activated TGF.Keywords
This publication has 42 references indexed in Scilit:
- Vasodilator effects of l-arginine are stereospecific and augmented by insulin in humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamicsNephrology Dialysis Transplantation, 2002
- Assessment of endothelial function of the renal vasculature in human subjectsAmerican Journal of Hypertension, 2002
- Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?Clinical Science, 2000
- Induction of microalbuminuria by l -Arginine infusion in healthy individuals: An insight into the mechanisms of proteinuriaAmerican Journal of Kidney Diseases, 1999
- L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationshipBritish Journal of Clinical Pharmacology, 1998
- Salt intake determines the renal response to L-arginine infusion in normal human subjectsKidney International, 1998
- l‐ARGININE INFUSION INDUCES HYPOTENSION AND DIURESIS/NATRIURESIS WITH CONCOMITANT INCREASED URINARY EXCRETION OF NITRITE/NITRATE AND CYCLIC GMP IN HUMANSClinical and Experimental Pharmacology and Physiology, 1992
- Dilator actions of arginine in human peripheral vasculatureClinical Science, 1991
- Role of growth hormone in the amino acid-induced acute rise in renal function in manKidney International, 1987